Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors Group.
Fiche publication
Date publication
mai 2024
Journal
Journal of the Endocrine Society
Auteurs
Membres identifiés du Cancéropôle Est :
Pr LEPAGE Côme
Tous les auteurs :
Chevalier B, Bonnet D, Lepage C, Perrier M, Borson-Chazot F, Abeillon J, Delobel JB, Jannin A, Hadoux J, Haissaguere M, Lombard-Bohas C, Walter T, Chardon L
Lien Pubmed
Résumé
Vasoactive intestinal peptide (VIP)-secreting tumors (VIPomas) are digestive neuroendocrine tumors in which the hormonal secretion is life-threatening. Biological confirmation is obtained by demonstrating an elevation in plasma VIP, usually using radioimmunoassay (RIA). In some cases, analytical interference is suspected. We developed 3 different techniques to detect interference in VIP RIA.
Mots clés
analytic interference, neuroendocrine tumor, vasoactive intestinal peptide
Référence
J Endocr Soc. 2024 05 23;8(7):bvae102